Biotech

All Articles

Metsera coordinate with Amneal to latch down GLP-1 source

.Along with very early phase 1 records now out in bush, metabolic condition ensemble Metsera is squa...

Rivus articles data to support muscle-sparing excessive weight drug claims

.Rivus Pharmaceuticals has revealed the records responsible for its phase 2 obesity succeed in cardi...

BMS pays out $110M to form T-cell therapy deal, helping Perfect buy opportunity to improve prioritized pipe

.Bristol Myers Squibb is paying Top Medicine $110 million ahead of time to establish reagents for ex...

Generate gains one more $1B-plus Significant Pharma relationship

.Novartis has actually printer inked an offer possibly worth more than $1 billion with Flagship-foun...

Metsera GLP-1 data piece discloses 7.5% weight loss at 36 days

.Just recently debuted Metsera is unfolding some period 1 information for its own GLP-1 receptor ago...

Flagship hopes biotechs group to Mirai to improve genetic medications

.Among the hereditary medicines arms race, Crown jewel Pioneering is introducing a brand new busines...

BioAge eyes $180M coming from IPO, exclusive placement for weight problems tests

.BioAge Labs is checking out all around $180 million in first proceeds from an IPO and also a person...

Merck's LAG-3 combo fails intestines cancer cells phase 3 research study

.An effort through Merck &amp Co. to open the microsatellite secure (MSS) metastatic intestines canc...

Spanish VC closes $200M life sciences fund

.Spain-based Asabys Partners has finalized a fund of 180 thousand europeans ($ 200 million), cash th...

BioAge produces $198M from IPO as weight problems biotech participates in Nasdaq

.BioAge Labs is actually generating just about $200 million using its Nasdaq IPO this morning, along...